{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:19:05Z","timestamp":1771881545630,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.autrev.2015.11.008","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T20:46:38Z","timestamp":1448570798000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adaptive immune regulation in autoimmune diabetes"],"prefix":"10.1016","volume":"15","author":[{"given":"Concetta","family":"Ferretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"La Cava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.11.008_bb0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0076","article-title":"Genetics of type 1 diabetes: what's next?","volume":"59","author":"Pociot","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0010","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2337\/db10-0699","article-title":"HLA class I and genetic susceptibility to type 1 diabetes: results from the type 1 Diabetes Genetics Consortium","volume":"59","author":"Noble","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.autrev.2015.07.006","article-title":"Gene\/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll-like receptors","volume":"14","author":"Gianchecchi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.autrev.2014.01.020","article-title":"Diagnosis and classification of autoimmune diabetes mellitus","volume":"13","author":"Canivell","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2015.11.008_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12022-014-9297-8","article-title":"Pancreatic pathology in type 1 diabetes mellitus","volume":"25","author":"Richardson","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0035","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.187.10.1549","article-title":"Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens","volume":"187","author":"Heath","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.11.008_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.autrev.2014.10.004","article-title":"The mechanisms behind Helminth's immunomodulation in autoimmunity","volume":"14","author":"Bashi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","article-title":"IL-27-induced modulation of autoimmunity and its therapeutic potential","volume":"14","author":"Meka","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nri2787","article-title":"Immune cell crosstalk in type 1 diabetes","volume":"10","author":"Lehuen","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2015.05.002","article-title":"Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM)","volume":"14","author":"Kakleas","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0060","doi-asserted-by":"crossref","first-page":"13838","DOI":"10.1073\/pnas.251531798","article-title":"Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets","volume":"98","author":"Naumov","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.11.008_bb0065","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2337\/diabetes.51.8.2481","article-title":"Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced","volume":"51","author":"O'Brien","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrd4231","article-title":"Targeting the pancreatic \u03b2-cell to treat diabetes","volume":"13","author":"Vetere","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2015.11.008_bb0075","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/346844a0","article-title":"Loss of pancreatic islet tolerance induced by \u03b2-cell expression of interferon-\u03b3","volume":"346","author":"Sarvetnick","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2015.11.008_bb0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/414792a","article-title":"\u03b2-Cell death during progression to diabetes","volume":"414","author":"Mathis","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2015.11.008_bb0085","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.168.3.1466","article-title":"In situ \u03b2 cell death promotes priming of diabetogenic CD8 T lymphocytes","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0896-8411(03)00039-8","article-title":"IL-1\u03b2, IFN-\u03b3 and TNF-\u03b1 increase vulnerability of pancreatic \u03b2 cells to autoimmune destruction","volume":"20","author":"Wachlin","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.11.008_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.0105-2896.2006.00421.x","article-title":"Regulatory T-cell physiology and application to treat autoimmunity","volume":"212","author":"Tang","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0100","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of \u03b2-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.11.008_bb0105","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2012.11.001","article-title":"Th17 cells in type 1 diabetes","volume":"280","author":"Shao","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0115","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/db11-0090","article-title":"Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes","volume":"60","author":"Ferraro","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0120","doi-asserted-by":"crossref","first-page":"205284","DOI":"10.1155\/2013\/205284","article-title":"The serum IL-6 profile and Treg\/Th17 peripheral cell populations in patients with type 1 diabetes","volume":"2013","author":"Ryba-Stanis\u0142awowska","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2015.11.008_bb0125","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.0900576","article-title":"Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells","volume":"183","author":"Bradshaw","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0135","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","article-title":"The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells","volume":"181","author":"Schneider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.autrev.2015.11.008_bb0145","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/eji.200738109","article-title":"Critical role of IL-2 and TGF-\u03b2 in generation, function and stabilization of Foxp3+CD4+ Treg","volume":"38","author":"Horwitz","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jmcb\/mjr040","article-title":"Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes","volume":"4","author":"Li","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaut.2011.06.002","article-title":"IL-7 uniquely maintains FoxP3+ adaptive Treg cells that reverse diabetes in NOD mice via integrin-\u03b27-dependent localization","volume":"37","author":"Li","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.11.008_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jmcb\/mjr040","article-title":"Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes","volume":"4","author":"Li","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0165","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.170.3.1304","article-title":"Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance","volume":"170","author":"Min","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006527","article-title":"Apoptosis of CD4+CD25high T cells in type 1 diabetes may be partially mediated by IL-2 deprivation","volume":"4","author":"Jailwala","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.11.008_bb0175","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2337\/db08-0138","article-title":"Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells","volume":"57","author":"Monti","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0180","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2015.11.008_bb0185","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.autrev.2015.11.008_bb0190","doi-asserted-by":"crossref","first-page":"12674","DOI":"10.1073\/pnas.1203795109","article-title":"Anti-IL-7 receptor-\u03b1 reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.11.008_bb0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autrev.2011.08.007","article-title":"Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes","volume":"11","author":"Kornete","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0200","doi-asserted-by":"crossref","first-page":"12668","DOI":"10.1073\/pnas.1203692109","article-title":"IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector\/memory T cells","volume":"109","author":"Penaranda","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.11.008_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jmcb\/mjr039","article-title":"Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?","volume":"4","author":"Lan","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fimmu.2014.00046","article-title":"Regulatory T cells as immunotherapy","volume":"5","author":"Singer","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0215","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.4049\/jimmunol.179.6.3638","article-title":"Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells","volume":"179","author":"Gaudreau","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/diabetes.54.1.78","article-title":"Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T-cells","volume":"54","author":"Kared","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0225","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.4049\/jimmunol.1400567","article-title":"Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes","volume":"194","author":"Bischoff","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20061631","article-title":"Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice","volume":"204","author":"Tarbell","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.11.008_bb0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1900\/RDS.2010.7.47","article-title":"Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4+ T cells into regulatory T cells and promotes immunotolerance in NOD mice","volume":"7","author":"Petzold","year":"2010","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.autrev.2015.11.008_bb0240","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.4049\/jimmunol.179.6.3638","article-title":"Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells","volume":"179","author":"Gaudreau","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/diabetes.54.1.78","article-title":"Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T-cells","volume":"54","author":"Kared","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0250","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/eji.200738108","article-title":"Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation","volume":"38","author":"Brusko","year":"2008","journal-title":"Eur J. Immunol."},{"key":"10.1016\/j.autrev.2015.11.008_bb0255","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nm.1993","article-title":"Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates","volume":"15","author":"Weaver","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2015.11.008_bb0260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/jaut.2002.0599","article-title":"Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism","volume":"19","author":"Grewal","year":"2002","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.11.008_bb0270","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clim.2011.02.004","article-title":"Complement C3 deficiency prevent against the onset of streptozotocin-induced autoimmune diabetes involving expansion of regulatory T cells","volume":"140","author":"Gao","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"Morimoto","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0280","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2567.1997.d01-2258.x","article-title":"Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-\u03b2 1 in PWM-stimulated PBMC and T cells","volume":"91","author":"Reinhold","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2015.11.008_bb0285","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/en.2010-0068","article-title":"Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor","volume":"151","author":"Tian","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.autrev.2015.11.008_bb0290","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S2213-8587(14)70115-9","article-title":"Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"2","author":"Griffin","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0295","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/eji.200737621","article-title":"Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation","volume":"37","author":"Schambach","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0300","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/db08-1154","article-title":"All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells","volume":"58","author":"Van","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2008.12.028","article-title":"Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice","volume":"47","author":"Stosi\u0107-Grujici\u0107","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0310","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2011.10.001","article-title":"Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment","volume":"37","author":"Bresson","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.11.008_bb0315","doi-asserted-by":"crossref","first-page":"e70056","DOI":"10.1371\/journal.pone.0070056","article-title":"Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.11.008_bb0320","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1196\/annals.1321.009","article-title":"Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies","volume":"1024","author":"Franchimont","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2015.11.008_bb0325","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cei.12078","article-title":"Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetes","volume":"172","author":"Pihl","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/dmrr.711","article-title":"Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study","volume":"23","author":"Lazar","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.autrev.2015.11.008_bb0335","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/pedi.12029","article-title":"Clinical application of regulatory T cells in type 1 diabetes","volume":"14","author":"Marek-Trzonkowska","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0340","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1600-6143.2003.00351.x","article-title":"Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with antiCD3 antibody","volume":"4","author":"Hering","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.autrev.2015.11.008_bb0345","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/156652412803833634","article-title":"Targeting regulatory T cells in the treatment of type 1 diabetes mellitus","volume":"12","author":"Cabrera","year":"2012","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.autrev.2015.11.008_bb0350","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI9918","article-title":"IL-10-producing T cells suppress immune responses in anergic tuberculosis patients","volume":"105","author":"Boussiotis","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2015.11.008_bb0355","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2337\/db11-1635","article-title":"Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice","volume":"61","author":"Parsa","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0360","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.3892\/mmr.2015.3809","article-title":"Interleukin-10 gene transfer into insulin-producing \u03b2 cells protects against diabetes in non-obese diabetic mice","volume":"12","author":"Xu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2015.11.008_bb0365","doi-asserted-by":"crossref","first-page":"e0127631","DOI":"10.1371\/journal.pone.0127631","article-title":"Combination of an antigen-specific therapy and an immunomodulatory treatment to simultaneous block recurrent autoimmunity and alloreactivity in non-obese diabetic mice","volume":"10","author":"Fousteri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.11.008_bb0370","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10875-008-9237-9","article-title":"The IL-2\/CD25 pathway determines susceptibility to T1D in humans and NOD mice","volume":"28","author":"Dendrou","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0375","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs \u03b2-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0380","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diacare.20.3.424","article-title":"Activated protein C resistance in type I diabetes","volume":"20","author":"Gruden","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2015.11.008_bb0385","doi-asserted-by":"crossref","first-page":"16356","DOI":"10.1074\/jbc.M111.325951","article-title":"Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice","volume":"287","author":"Xue","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2015.11.008_bb0390","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-12-800174-5.00013-2","article-title":"Activated protein C and its potential applications in prevention of islet \u03b2-cell damage and diabetes","volume":"95","author":"Xue","year":"2014","journal-title":"Vitam Horm"},{"key":"10.1016\/j.autrev.2015.11.008_bb0395","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4049\/jimmunol.179.2.744","article-title":"Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells","volume":"179","author":"Bollyky","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0400","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4049\/jimmunol.0900191","article-title":"CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta","volume":"183","author":"Bollyky","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0405","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11892-012-0297-0","article-title":"The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation","volume":"12","author":"Bollyky","year":"2012","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.autrev.2015.11.008_bb0410","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/db13-1658","article-title":"Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis","volume":"63","author":"Bogdani","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0415","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/diabetes.53.8.1995","article-title":"Flt3-ligand treatment prevents diabetes in NOD mice","volume":"53","author":"Chilton","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2015.11.008_bb0420","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaut.2009.11.010","article-title":"Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment","volume":"34","author":"Van Belle","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.11.008_bb0425","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2008.12.017","article-title":"NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner","volume":"30","author":"Diana","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2015.11.008_bb0430","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1074-7613(02)00473-9","article-title":"NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic \u03b2 cells","volume":"17","author":"Beaudoin","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2015.11.008_bb0435","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4049\/jimmunol.174.3.1196","article-title":"Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes","volume":"174","author":"Chen","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0440","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/eji.201343910","article-title":"Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes","volume":"4","author":"Beaudoin","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.11.008_bb0445","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/db09-0497","article-title":"Targeting B-cells mitigates autoimmune diabetes in NOD mice: what is plan B?","volume":"58","author":"Smith","year":"2009","journal-title":"Diabetes"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215002396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215002396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T20:19:54Z","timestamp":1567369194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215002396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1568997215002396"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.11.008","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive immune regulation in autoimmune diabetes","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}